Anbogen Therapeutics, Inc.

About Anbogen Therapeutics, Inc.

Anbogen Therapeutics, Inc. is a precision oncology company focused on addressing unmet medical needs through targeted cancer therapies. Their mission is to transform the lives of cancer patients by leveraging scientific expertise and integrating research with clinical development.

Products & Services

R&D Platform:A platform for developing precision oncology drugs aimed at addressing unmet medical needs through targeted therapy.

R&D Pipeline:Innovative cancer therapies under development, leveraging the team's scientific expertise and experience in drug development.

Specialties

Precision Oncology Targeted Cancer Therapies AI Drug Discovery

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: A+ T: - FT: A+	A: 7300000 MR: - FA: USD 7.3M FAN: 7300000	D: 2024-07-01 FD: 2024-07-01	1 investors
2	RT: Series A T: - FT: Series A	A: 12500000 MR: - FA: 12.5 million FAN: 12500000	D: 2024-01-31 FD: 2024-01-31	4 investors

A+ Latest

2024-07-01

$7.3M

1 investor (Pro only)

Series A 2024-01-31

$12.5M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

T

Tsu-an Hsu

CEO and CSO

J

Joe Hsueh

President and Chief Operating Officer

M

Mark Horng

Chief Medical Officer

C

Chih-Yi Hsieh

Special Medical Advisor

A

Angus Wu

VP Business Development

E

Endy Yang

Vice President of Finance and Accounting

View 9 more team members with Pro

Unlock Full Team Directory

Recent News